Andrew Huberman· PhD
We cannot say that any one individual treatment works for everybody. There are fairly large percentages of people that won't respond to one set of treatments or another, and therefore one has to try different ones.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
We cannot say that any one individual treatment works for everybody. There are fairly large percentages of people that won't respond to one set of treatments or another, and therefore one has to try different ones.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Now, up until now, I've been talking about the fact that people are getting relief from these treatments, but sadly, in the case of OCD, there is a significant population that simply does not respond to CBT or to SSRIs, or to their combination, which is why psychiatrists also explore the combination of SSRIs and neuroleptics or drugs that tap into the so-called dopamine system or the glutamate system.
but there's still about 30 of patients that still suffer from OCD and some of them have severe OCD sometimes it's moderate to severe
The these are all fabulously helpful uh therapies for a variety of patients, but there's still about 30% of patients that still suffer from OCD and some of them have severe OCD. Sometimes it's moderate to severe and those are the patients that I'm really motivated to try to help.